Postoperative respiratory obstruction and hypoxaemia may have a significant adverse impact on postoperative outcome 1, 2 . The significance of a diagnosis of obstructive sleep apnoea (OSA) and the need for routine specific questioning during preoperative evaluation are well-recognised 3, 4 . In a preliminary study 5 we found that a simple preoperative OSA-risk assessment (using body mass index [BMI] >27, history of witnessed apnoeas or daytime somnolence and airway abnormality on examination) was predictive of airway obstruction and oxygen desaturation on the first postoperative night in patients having routine postoperative ward management. In a retrospective study, serious complications after joint replacement surgery increased from 9 to 24% with a definite diagnosis of OSA 2 . OSA is also associated with other conditions likely to increase perioperative risk, including hypertension, heart failure, cardiac arrhythmia, asthma, chronic obstructive airways disease and gastro-oesophageal reflux 6 .
Recommendations for anaesthesia in patients with a likely diagnosis of OSA include the avoidance of opioids where possible. The incidence and significance of hypoxaemic episodes related to postoperative opioid infusions and respiratory obstruction is documented 7 . Other options for postoperative analgesia include anti-inflammatory drugs, NMDA (N-methyl D-aspartate) receptor blockade with ketamine and use of tramadol to increase brainstem catecholamines, although metabolites of tramadol have significant opioid effects. We randomised patients with a probable diagnosis of OSA, based on BMI, history and airway examination, to have either standard morphine patient-controlled analgesia (PCA) or an opioidsparing analgesia protocol, and measured the incidence of early postoperative respiratory events.
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SUMMARY
Symptoms of obstructive sleep apnoea are common in patients presenting for surgery and are associated with increased morbidity. Analgesia contributes significantly to postoperative respiratory depression and obstruction, so we compared standard morphine patient-controlled analgesia with an opioid-sparing protocol (tramadol patient-controlled analgesia, parecoxib and rescue-only morphine) in these patients. Sixty-two patients presenting for elective surgery with body mass index ≥28 and signs or symptoms suggesting obstructive sleep apnoea were randomised to receive either the opioid or opioid-sparing postoperative analgesia protocol, with continuous respiratory monitoring for 12 hours on the first postoperative night. The number of respiratory events (apnoeas and hypopnoeas) and oxygen desaturations were compared. There was no difference between treatment groups in the number of obstructive apnoeas, hypopnoeas or central apnoeas. However, central apnoeas and a rate of respiratory events >15 per hour were related to postoperative morphine dose (P=0.005 and P=0.002). In patients at risk of obstructed breathing, intention to treat with an opioid-sparing analgesia protocol did not decrease the rate of respiratory events, although the rate was still related to the total morphine dose. Patients were recruited following routine screening at the pre-admission clinic prior to elective surgery. Allocation to opioid (morphine PCA) or opioidsparing analgesia protocols was made according to a computer-generated random sequence for 100 patients, provided in a sealed envelope to the treating anaesthetist on the day of surgery. Allocation was not revealed until after enrolment and immediately prior to surgery. History and physical examination used to assess probable OSA risk included: 1) snoring, witnessed apnoeas or excessive daytime somnolence (epworth sleepiness scale [eSS] >9) 8, 9 , 2) difficulty with endotracheal intubation or airway management with previous anaesthesia 10 , 3) hypertension or heart failure, 4) BMI ≥28 kg/m 2 , 5) thyromental distance <6.5 cm 11 , 6) pharyngeal grades III to IV (reduced space at base of tongue on oral examination 11 ), 7) absence of overbite (ability to place lower incisors in front of upper if teeth present), 8) cricomental space >1.5 cm (perpendicular to line between cricoid and mandible, used to exclude OSA risk 11 ). Patients with BMI ≥28 kg/m 2 and any two of the above history or physical examination findings were considered as probable OSA risk.
Inclusion criteria: patients who were evaluated as probable OSA risk at the preadmission clinic prior to elective surgery with general anaesthesia and were expected to require opioid analgesia or equivalent in the postoperative period.
exclusion criteria: patients who were currently using continuous positive airway pressure therapy or were diagnosed with OSA, cardiothoracic or major abdominal surgery, elective postoperative ventilation in the intensive care unit, or who had tracheostomy or previous adverse reaction to or known contraindication to the use of tramadol, morphine, parecoxib or ketamine.
General anaesthesia technique was at the discretion of the treating anaesthetist. The use of supplemental regional anaesthesia was encouraged and long-acting sedative agents avoided.
All patients received intravenous paracetamol 1 g six hourly. All patients in the opioid-sparing group received 40 mg intravenous parecoxib prior to skin closure and intravenous tramadol 2 mg/kg during surgery followed by PCA tramadol (bolus 10 mg, 10 minute lockout period). At the discretion of the treating anaesthetist, intravenous ketamine 0.3 mg/kg in the recovery room followed by 0.1 mg/kg/hour for 18 to 24 hours could be used for supplemental analgesia in the opioid-sparing group. Those in the opioid group received a loading dose of morphine during surgery and in the recovery room, followed by PCA morphine (1 mg intravenous bolus and five-minute lockout).
A portable respiratory monitor (Somte, Compumedics
Ltd, Abbotsford, Vic.) was connected to patients in the recovery room after surgery. This varied from 1400 to 1800 hours, but was generally between 1700 and 1800 hours. The monitor was collected at 0800 hours the following day and the recording between 1900 and 0700 hours used for analysis of respiratory events. The investigator performing analysis of the Somte recordings was blinded to the patient's treatment group. Data recorded were thoracic and abdominal respiratory movement measured via inductive bands, airflow (nasal pressure), finger pulseoximetry, movement and position (supine or lateral). An oxygen mask was applied over the nasal prong sensors and postoperative supplemental oxygen routinely prescribed. Other data collection included analgesic doses and time of administration from the PCA device, verbal pain scores and side-effects of analgesia. The Somte respiratory analysis program was used to identify apnoeas and hypopnoeas from the nasal catheter 'flow' signal and desaturations from the oximeter channel of the Somte monitor. Hypopnoeas were defined as <30% of the preceeding flow amplitude for 10 seconds. Minimum apnoea duration was 10 seconds. Thoracic and abdominal 'effort flow' channels were used to differentiate obstructive and central apnoeas. The entire 12-hour recording was viewed with two minutes per screen to check the events marked by the automatic software and correct as required.
The primary outcome variable was the number of apnoeas/hypopnoeas, (central or obstructive) in the 12-hour postoperative monitored period to 0700 hours. Our initial study 5 found a rate of respiratory events of 35 (SD 21) events per hour in the postoperative period in patients selected by similar criteria. If reduction of the rate of respiratory events to <20 per hour is estimated to be clinically significant, then for α 0.05 and power 0.8 the study requires 31 patients per treatment group. Linear regression analysis was used to find patient and treatment factors associated with respiratory events (apnoeas, hypopnoeas and oxygen desaturations). Data were checked for skewed distribution and outlying points and correlation coefficents obtained for each factor. Logistic regression was used to determine predictors of a rate of respiratory events >15 per hour with calculation of odds ratio and 95% confidence interval.
ReSULTS
A total of 94 patients were approached and 65 were recruited and randomised. Three patients were withdrawn following early postoperative complications. One patient in the opioid group had intraoperative bronchospasm and surgery was cancelled. In the opioid-sparing group one patient was withdrawn because of severe postoperative vomiting and another following haemodynamic instability in the recovery room. Data from 30 patients in the opioid group and 32 in the opioidsparing group were analysed.
The patient characteristics of the opioid and opioid-sparing treatment groups are described in Table 1 . The groups were comparable for age, gender, history of snoring and witnessed apnoeas during sleep. However, the opioid-sparing group had a higher mean BMI, but lower mean eSS score than the opioid group (Table 1) . Patients had either orthopaedic surgery (shoulder, hip or knee joint replacement or spinal surgery) or general surgery (abdominal hernia repairs or chest wall surgery). Nerve or plexus blocks prior to surgery were used in five patients in the opioid group and six patients in the opioid-sparing group (Table 1) . The different analgesia protocols resulted in a significantly higher postoperative morphine dose in the morphine PCA group (23.8±20.8 mg vs 4.3±5.1 mg, P <0.001), however, eight patients in the morphine PCA group used <10 mg in the monitored period and eight patients in the opioid-sparing group received 10 mg of morphine as rescue analgesia.
The primary end-point, total respiratory events during the 12 hour postoperative period, was not significantly different between the opioid and opioidsparing groups (146±139 vs 125±159, P=0.59, Figure 1 ). The length of time during the monitored period with SpO 2 <90% was similar (P=0.31) and the highest pain scores recorded were also comparable between groups (3.9±2.3 vs 3.0±2.0, P=0.13).
There was no significant difference between groups in obstructive or central apnoeas, or consequent number of oxygen desaturations (Table 2 ). However, there was a trend towards more frequent central apnoeas in the opioid group (Figure 1) .
Across both groups, the frequency of apnoeas was correlated with the number of desaturation events ≥4% (P <0.001). The total respiratory events (apnoeas [obstructive and central] and hypopnoeas) was predicted by increased eSS score (P <0.001) and by the total postoperative morphine dose delivered between arrival in the recovery room and 0700 hours the following day (P=0.03, Figure 2 ). Postoperative morphine dose also predicted central apnoeas (P=0.005, Table 3 ), but the postoperative tramadol dose was not predictive of respiratory events (P=0.48).
Patients having respiratory events with a frequency comparable to that for a diagnosis of OSA on a routine sleep study (>15/hour, Table 4 ), had higher eSS scores (P=0.030), postoperative cumulative morphine dose (P=0.002) and duration of desaturation ≥4% (P=0.021). Previous witnessed apnoeas were of borderline significance (P=0.051).
DISCUSSION
Patients with OSA have episodes of obstruction and asphyxia while asleep that result in arousal following apnoea and oxygen desaturation. Residual sedation and analgesia after surgery may increase the frequency and severity of these episodes via several mechanisms 12 . There may be a greater reduction in the tone of pharyngeal muscles, loss of the arousal response, which normally terminates an apnoea, and a decreased responsiveness to hypoxia and hypercarbia. even though OSA patients rarely achieve the deep sleep stages commonly associated with OSA in the early postoperative period, they have increased risk of complications 2 . Most patients with OSA have a combination of obstructive and central apnoeas and some apnoeas may be classified as 'mixed', although we have not included that definition in this study. It is not clear from the literature whether postoperative morphine has similar effects in increasing both central and obstructive apnoeas. Sedation with morphine increases upper airway obstruction, but central depression also reduces or abolishes respiratory muscle activity during apnoea. Morphine dose varied widely between patients in this study, but across both groups postoperative dose was significantly related to the frequency of central apnoeas and to the total number of respiratory events, obstructive and central. Patients with OSA are at increased risk because of an underlying mechanism of airway obstruction likely to potentiate the effects of morphine.
We were unable to demonstrate any benefit from an analgesia protocol replacing morphine PCA with tramadol PCA and adjunct analgesics. This may have been a consequence of a lower average rate of observed postoperative respiratory events compared with a previous study 5 . Factors contributing to this probably included a lower average BMI and fewer OSA risk factors in the present study. Failure of the 'opioid-sparing' analgesia protocol may also be the result of failure to completely avoid morphine use in the opioid-sparing group or to the relatively small doses of morphine used by some patients in the opioid group. Patients having more major surgery and requiring higher morphine doses could have been recruited according to the inclusion criteria. However, our anaesthetists were reluctant to recruit these patients to a trial with randomisation to tramadol versus morphine analgesia because of a perceived reduced efficacy of tramadol, despite the possibility of combining the tramadol with both parecoxib and ketamine. Maximum dosage of tramadol was often not reached prior to the use of rescue morphine in the opioid-sparing group. Lack of efficacy of tramadol PCA was not suggested by the pain scores in this study which were low and similar for the two groups.
Using history and examination at the pre-admission clinic to select patients with at least two OSA risk factors identified a group in which 30% had a frequency of postoperative respiratory events >15/hour and the average number of desaturations >4% was 12/hour. A simpler method of identifying these patients would be to use the "STOP Questionnaire" validated in Canada by Chung et al 13 .
Positive responses to two of the four questions, or to one together with a high BMI or neck circumference, would provide similar criteria to those used in this study.
We did not investigate the relationship between sleep stages and respiratory obstruction in this study. Patients were monitored on the first postoperative night, during which analgesic use and residual sedation are likely to be greatest. Many patients also had relatively minor surgery and were only admitted to the hospital for one night. Typically however, sleep apnoea events are associated with slow-wave and ReM sleep that does not rebound until several days after the surgery and period of sleep deprivation.
The significance of episodes of hypoxaemia in the postoperative period is well established and it is associated with cardiovascular events, delirium and delayed wound healing 14 . Successful preoperative intervention to improve outcome in patients with signs and symptoms of OSA has not been reported. However, for the postoperative period, the literature supports increased respiratory monitoring, avoidance of the supine position, careful use of supplemental oxygen and consideration of continuous positive airway pressure 12, 15 . This study suggests that, although avoidance of sedation and large opioid doses is desirable, small reductions in morphine dose achieved by use of the 'atypical-opioid' tramadol and nonsteroidal anti-inflammatory drugs, are not effective in avoiding postoperative respiratory obstruction.
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